Hematopoietic cells in bone marrow smears (B) show a mildly increased proportion of granulocytes and a decrease of erythrocytes, while the percentage of middle–late stage erythroblasts (small round cells with dark blue nuclei) show a mild increase within the erythrocyte series. by Ji-ye Yin (5658820)

Bortezomib in combination with the PLK1 inhibitor BI 2536 induces a significant downregulation of the total levels and phosphorylation of Bcr-Abl, a decrease of downstream phosphorylated STAT5 and a caspase-dependent cell death in TKIs-resistant and –sensitive K562 cell lines. by Octavian Bucur (470431)

“…While single treatments did not significantly change the morphology and number of the cells, the combined treatment induced a change in morphology/shape and a decrease in the number of the cells. …”

The requirement of non-enhancement of local extrema is a way of restricting the class of possible image operations by formalizing the notion that new image structures must not be created with increasing scale, by requiring that the value at a local maximum must not increase and that the value at a local minimum must not decrease. by Tony Lindeberg (435099)

“…<p>The requirement of non-enhancement of local extrema is a way of restricting the class of possible image operations by formalizing the notion that new image structures must not be created with increasing scale, by requiring that the value at a local maximum must not increase and that the value at a local minimum must not decrease.…”

Baseline characteristics of the study population (A) and medication (B). by Orna Avlas (446424)

Ultrasonographic images. by Robert Hermes (385818)

A novel mechanism of cone photoreceptor adaptation by Marcus H. C. Howlett (3921143)

“…<div><p>An animal’s ability to survive depends on its sensory systems being able to adapt to a wide range of environmental conditions, by maximizing the information extracted and reducing the noise transmitted. …”

R code for analysis of a single survey. by Neal Alexander (18417)

Models for changes in DNA methylation of the <i>WNT5A</i> promoter B region during progression of osteoblast cells to osteosarcoma. by Himani Vaidya (3179403)

“…In osteosarcoma cells, the level of H3K4me3 decreases in the promoter B region R6 and unmethylated H3 increases, allowing the Dnmt3L/Dnmt3a/b complex to bind to the H3 and <i>de novo</i> methylate the DNA, leading to reduced transcription of promoter B. …”

Intensity ratios between Nogo-A-Δ20 in the presence vs. absence of ECLs. by Viviane Zelenay (835735)

“…<p><b>A</b>: 1 to 1 ratio (ECL2) at pH 7.4 and 6°C. <b>B</b>: 1 to 3 ratio (ECL2) at pH 7.4 and 6°C. …”

Inactivation of the <i>WNT5A</i> Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2 by Himani Vaidya (3179403)

“…Promoter B but not promoter A transcripts are decreased or nearly undetectable in the SaOS-2 and U2OS cell lines and osteosarcoma tumor tissues. …”

Epitope specific antibody response in EV-A71 infected HFMD patients. by Lei You (542435)

“…Serum samples showing a > 2-fold decrease in titer against variant(s) compared with wild-type were defined as sensitive to that variant(s) and results from these samples are highlighted in orange. …”

Regions of decreased activation in processing emotional facial stimuli in ALS patients compared to healthy controls (all emotions averaged). by Helena E. A. Aho-Özhan (3221430)

Alterations in interaction profiles from G1 to S phase. by Andrew J. Fritz (638393)

“…Values are color coded with green increasing the most from G1 to S and red decreasing the most. The types of alterations in interaction are displayed for WI38 and 10A in the center rows.…”

Geographic and altitudinal distribution COVID-19 in a) North America, b) Central America and c) South America. by Christian Arias-Reyes (10491992)

Rac and PKB activities are required for a late phase of cerebellar LTP. by Claire Jackson (362873)

“…<p><b>A</b>) Addition of the Rac inhibitor EHT1864 (50 µM; n = 7) to pipette solution decreases LTP duration. …”

Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

ApoA-I inhibits endothelial exocytosis via SR-BI. by Scott J. Cameron (838315)

Measurements of bone mineral density, strength and formation. by Armando R. Irizarry (422739)

“…<p>At 13 weeks old, (A) <i>Slc13a5</i>^-/- mice had similar BMD in distal femur (DF) and 5^th lumbar vertebrae (LV5) to <i>Slc13a5</i>^<i>+/+</i> mice, but had decreased BMD in mid femur (MF), and a trend with decreased bone strength (B) (P = 0.096), and decreased calcein incorporation (C) compared with <i>Slc13a5</i>^<i>+/+</i> (n = 9 each group). …”

Cu(I) Complexes of 3,3‘-Polymethylene Bridged Derivatives of 2,2‘-Bi-1,10-Phenanthroline by Elvira C. Riesgo (2960946)

“…The intensity of the long wavelength metal−ligand charge-transfer absorption band decreases as the 3,3‘-bridge is shortened. Interaction between the two copper centers is evidenced by a splitting of the oxidation wave, and this splitting increases as the Cu−Cu distance is decreased.…”